Quarterly Transactions Made in Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA). The information is specifically focused on institutions that hold shares of Lyra Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 164,090 | 158,697 | 322,787 | 355,976 | 143,776 | 499,752 | -176,965 | |
Q4 2021 | 90,164 | 143,566 | 233,730 | 288,231 | 238,292 | 526,523 | -292,793 | |
Q1 2022 | 95,253 | 8,835 | 104,088 | 130,512 | 76,290 | 206,802 | -102,714 | |
Q2 2022 | 8,618,611 | 5,819,907 | 14,438,518 | 125,109 | 68,185 | 193,294 | 14,245,224 | |
Q3 2022 | 157,335 | 92,242 | 249,577 | 273,292 | 200 | 273,492 | -23,915 | |
Q4 2022 | 343,917 | 43,406 | 387,323 | 414,839 | 0 | 414,839 | -27,516 | |
Q1 2023 | 20,118 | 1,846,623 | 1,866,741 | 180,513 | 0 | 180,513 | 1,686,228 | |
Q2 2023 | 10,013,121 | 5,501,037 | 15,514,158 | 643,211 | 0 | 643,211 | 14,870,947 | |
Q3 2023 | 968,460 | 166,610 | 1,135,070 | 2,487,395 | 0 | 2,487,395 | -1,352,325 | |
Q4 2023 | 2,604,193 | 7,447,412 | 10,051,605 | 472,300 | 0 | 472,300 | 9,579,305 | |
Q1 2024 | 4,910,588 | 4,351,424 | 9,262,012 | 5,590,671 | 0 | 5,590,671 | 3,671,341 | |
Q2 2024 | 6,359,502 | 1,750,292 | 8,109,794 | 2,110,199 | 0 | 2,110,199 | 5,999,595 | |
Q3 2024 | 1,054,840 | 1,793,866 | 2,848,706 | 1,895,172 | 0 | 1,895,172 | 953,534 |